CVS Health Beats Q1, Uplifts 2026 Guidance on Aetna Momentum
TL;DR Summary
CVS Health beat Q1 estimates across all segments, delivering adjusted earnings of $2.57 per share on $100.43 billion in revenue and raising full-year guidance to $7.30–$7.50 per share and at least $405 billion in revenue, driven by improving performance in Aetna and ongoing cost cuts, store closures, and leadership changes as part of its turnaround; shares rose in premarket trading.
- CVS blows past estimates, hikes outlook as insurance business outperforms CNBC
- CVS Boosts Outlook for 2026 After Aetna Profits Increase Bloomberg
- CVS’s Results Add to Positive Momentum for Health Insurance Industry WSJ
- Jim Cramer Says “I Think That CVS Will Give You a Good Quarter” Yahoo Finance
- CVS Profits Eclipse $2.9 Billion As Aetna Health Plan Costs Ease Forbes
Reading Insights
Total Reads
0
Unique Readers
11
Time Saved
4 min
vs 5 min read
Condensed
94%
931 → 60 words
Want the full story? Read the original article
Read on CNBC